Published in Gene Therapy Weekly, November 13th, 1995
According to researcher Heather L. Davis of the Loeb Medical Research Institute, Ottawa, Ontario, Canada, nucleic acid vaccine technology will not only overcome many of the problems associated with current vaccine approaches, but will also be relatively inexpensive to produce. This will make it possible for developing nations to vaccinate populations currently unable to afford prevention from life-threatening diseases.
Davis made her remarks in an invited address to the 35th...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.